Cartesian Therapeutics In... (RNAC)
17.58
-1.26 (-6.69%)
At close: Mar 03, 2025, 3:59 PM
17.50
-0.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Cartesian Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Cash & Equivalents | 76.91M | 106.44M | 114.06M | 138.69M | 90.17M | 37.4M | 70.7M | 58.73M | 32.47M | 16.59M |
| Short-Term Investments | n/a | 28.16M | 14M | n/a | n/a | n/a | 25.94M | 25.48M | 4.13M | n/a |
| Long-Term Investments | 2M | 2M | 2M | 1.75M | 1.38M | 279K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.38M | 1.34M | 1.47M | n/a | n/a | -1 | 329K | 438K | 1.88M | 1.13M |
| Receivables | 8.85M | 9.86M | 9.91M | 7.22M | 5M | n/a | 63K | 215K | 824K | 674K |
| Inventory | n/a | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.97M | 3.39M | 6.47M | 5.43M | 1.77M | 4.67M | 4.02M | 2.46M | 1.63M | 1.85M |
| Total Current Assets | 90.73M | 148.14M | 144.44M | 151.34M | 96.67M | 42.08M | 98.68M | 86.82M | 38.91M | 19.11M |
| Property-Plant & Equipment | 12.18M | 14.41M | 11.97M | 12.34M | 1.52M | 2.13M | 2.09M | 2.05M | 2.03M | 1.98M |
| Goodwill & Intangibles | 198.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 214.32M | 17.75M | 15.44M | 14.09M | 2.9M | 2.41M | 2.42M | 2.48M | 3.91M | 3.12M |
| Total Assets | 305.05M | 165.89M | 159.88M | 165.44M | 99.57M | 44.48M | 101.1M | 89.3M | 42.82M | 22.23M |
| Account Payables | 3.15M | 316K | 224K | 443K | 500K | 1.1M | 1.61M | 3.88M | 2.18M | 351K |
| Deferred Revenue | 2.31M | 593K | 53.88M | 72.05M | 1.67M | 959K | 787K | 1.84M | 1.31M | 3.02M |
| Short-Term Debt | 2.17M | 10.08M | 7.01M | 908K | 19.28M | 21.39M | n/a | 4.07M | n/a | 2.58M |
| Other Current Liabilities | 60.58M | 23.93M | 17.89M | 8.15M | 24.75M | 11.7M | 8.58M | 3.92M | 3.8M | 3.28M |
| Total Current Liabilities | 68.21M | 25.08M | 72.25M | 81.55M | 34.94M | 35.14M | 10.97M | 13.71M | 7.29M | 9.23M |
| Long-Term Debt | -313.29M | 27.84M | 28.27M | 34.44M | n/a | n/a | 21.04M | 7.98M | 11.86M | 4.82M |
| Other Long-Term Liabilities | 342.62M | 19.14M | 25.42M | 28.71M | 41.55M | 938K | 1.35M | 222K | 395K | 94.56M |
| Total Long-Term Liabilities | 677.02M | 46.98M | 65.11M | 101.89M | 56.23M | 14.76M | 38.31M | 20.64M | 14.54M | 100.75M |
| Total Liabilities | 745.23M | 72.06M | 137.36M | 183.44M | 91.17M | 49.9M | 49.29M | 34.34M | 21.84M | 109.98M |
| Total Debt | 10.96M | 37.92M | 35.28M | 35.35M | 19.28M | 21.39M | 21.04M | 12.04M | 11.86M | 7.4M |
| Common Stock | 16K | 15K | 12K | 11K | 9K | 3K | 3K | 1K | n/a | n/a |
| Retained Earnings | -614.65M | -394.94M | -430.32M | -404.63M | -335.75M | -280.4M | -216.9M | -151.58M | -111.51M | -83.88M |
| Comprehensive Income | -4.6M | -4.56M | -4.57M | -4.56M | -4.52M | -4.56M | -4.42M | -4.59M | -4.99M | -3.88M |
| Shareholders Equity | -440.18M | 93.83M | 22.52M | -18.01M | 8.4M | -5.42M | 51.81M | 54.96M | 20.99M | -87.75M |
| Total Investments | 2M | 30.16M | 16M | 1.75M | 1.38M | 279K | 25.94M | 25.48M | 4.13M | n/a |